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Importance of Symptomatic Cerebral Infarcts on Cognitive 
Performance in Patients with Alzheimer’s Disease
The coexistence of cerebral infarcts and Alzheimer’s disease (AD) is common, but the 
influence of symptomatic cerebral infarcts on cognition is uncertain in AD. We hypothesize 
that symptomatic cerebral infarcts may provide an additive cognitive factor contributing to 
dementia in the AD population. We studied 1,001 clinically probable or possible AD 
patients in the Alzheimer Disease Research Center (ADRC) database. Linear regression was 
used to evaluate for an association between symptomatic cerebral infarcts and memory, 
language, executive function, abstract reasoning, and visuospatial performance, 
separately. Models were adjusted for covariates including age, gender, education, 
ethnicity, hypertension, diabetes mellitus, heart disease, clinical dementia rating, the 
presence of silent cerebral infarcts, and multiplicity or location of infarcts. Clinical history 
of stroke was present in 107 patients, radiological infarcts in 308 patients, and 68 patients 
with both were considered to have symptomatic infarcts. Adjusting for all covariates, AD 
patients with symptomatic infarcts had more impairment of executive function (P < 0.05). 
The influence of cerebral infarcts is neither general nor diffuse, and the presence of clinical 
history may have a more important influence on executive performance in AD. 
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INTRODUCTION 
Both Alzheimer pathology and cerebral infarcts are common in 
older people, making the influence of cerebral infarcts on cog-
nition a matter of interest (1-3). Several magnetic resonance 
imaging (MRI)-based studies have documented that silent or 
symptomatic infarcts are associated with poorer cognitive per-
formance, cognitive decline, or increased likelihood of demen-
tia in the community (4-6). Pure vascular dementia, although 
uncommon, may result from cerebral infarcts (7).
  However, in Alzheimer’s disease (AD) patients, the contribu-
tion of vascular lesions to cognitive impairment is uncertain. 
Detection of vascular cognitive burden in AD may be helpful in 
differentiating between mixed dementia (AD with infarcts) and 
pure AD, and to allow strategies to prevent recurrent vascular 
injury. 
  The results from previous studies are inconsistent. Some 
studies have suggested that patients with AD and concomitant 
cerebrovascular lesions had poorer cognitive performance than 
those without (8-10), whereas other studies have suggested that 
vascular lesions did not have an important effect on the clinical 
features including cognitive performance (11-13). These differ-
ing findings may be the result of different examined stages of 
AD (10), relative small numbers (< 30) of AD patients with cere-
bral infarcts (8, 10-13), and exclusion of large infarcts (8, 12, 13). 
  Patients with cerebral infarcts are a heterogeneous group 
with respect to clinical evidence (symptomatic or silent), loca-
tion, volume, and multiplicity. Therefore, a larger sample may 
be needed to study the influence on cognition (14). Additional-
ly, the importance of clinical history of stroke, which is often 
neglected in autopsy-based AD studies, might be studied to-
gether with other radiological features of cerebral infarcts and 
other covariates of AD to elucidate the influence of cerebral in-
farct in AD (11-13). Separation of symptomatic infarcts from si-
lent infarcts is important because they have a different clinical 
significance in daily practice. Here we have examined the rela-
tionship of symptomatic cerebral infarcts to cognition in AD 
using a large database including 16 yr of data from an Alzheim-
er’s Disease Research Center (ADRC). 
MATERIALS AND METHODS
Patient selection
The study population consisted of subjects enrolled in the ADRC 
at Columbia University Subjects underwent standardized clinical 
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chiatric examination, neuropsychological testing, laboratory 
tests, and neuroimaging. Diagnoses are determined at a weekly 
consensus conference. Diagnosis of AD is based on National 
Institute of Neurological Communicative Disorders and Stroke-
Alzheimer’s Disease and Related Disorders Association (NIN-
CDS-ADRDA) criteria (15). Details about the process have been 
published elsewhere (16, 17).
  Information on stroke history was obtained from the patient 
and/or caregiver through structured questions. Neurological 
findings supporting a history of a stroke were documented after 
examination. Clinical stroke was defined by either symptoms 
(history) or signs (examination) that were indicative of stroke. 
In recent years, nearly all subjects have undergone computed 
tomography (CT) or MRI as part of their clinical evaluation. The 
interpretation of the neuroimaging data by the neuroradiologist 
was blinded to patient information other than “dementia” and 
was encoded in a database. A radiological infarct was defined 
as an area of hypodensity on brain CT scan or hyperintensity 
on T2-weighted brain MRI scan accompanied by hypointensity 
on T1-weighted images (4). White matter T2 hyperintensities 
without T1 changes, or dilated perivascular spaces, were not 
considered to be cerebral infarcts. Symptomatic infarcts were 
defined as having both radiological infarcts and clinical history 
of stroke. Silent infarcts were diagnosed in those patients show-
ing radiological infarct without clinical history of stroke. 
  Between July 1991 and November 2005, 1,781 patients were 
diagnosed with AD, and of these, 780 patients were excluded 
due to absence of information about stroke history (n = 86) 
and/or absence of information about brain imaging (n = 728). 
Among the remaining 1,001 AD patients, a clinical history of 
stroke was present in 107 patients, and radiological infarcts in 
308 patients. Sixty-eight patients with both were considered as 
having symptomatic infarcts. 
  AD patients that were included in this study were less edu-
cated (11.1 vs 11.6 yr, P = 0.02), more likely to be Hispanic (27% 
vs 17%, P < 0.001), more likely to have hypertension (49% vs 
41%, P = 0.003), and less likely to have heart disease (11% vs 
14%, P = 0.02) than the 780 excluded AD patients. There were 
no significant differences between the included and excluded 
AD patients regarding age, gender, and the proportion with dia-
betes mellitus. 
Neuropsychological evaluation
In order to evaluate the influence of symptomatic cerebral in-
farcts on the cognitive performance of AD patients, selected 
neuropsychological tests were grouped into the following cog-
nitive domains and converted into domain measures (16, 17). 
The memory domain included the total recall and delayed re-
call of the Selective Reminding Test and the recognition com-
ponents of a multiple-choice version of the Benton Visual Re-
tention Test. The executive function domain included phone-
mic fluency (a controlled oral word association test) and cate-
gorical fluency (animals and vegetables). The language domain 
included the total naming score for 15 selected items from the 
Boston Naming Test and the first 6 items from the repetition 
and comprehension subsets of the Boston Diagnostic Aphasia 
Examination. The visuospatial domain included the 5-item 
Rosen Drawing Test and the matching component of the multi-
ple choice version of the Benton Visual Retention Test. The ab-
stract reasoning domain included the age-scaled score of the 
revised Wechsler Adult Intelligence Scale (WAIS-R) similarities 
subtest and the identities and oddities subtest of the Dementia 
Rating Scale. 
  In order to define the cognitive domains, the results of each 
of the 12 baseline individual tests were first transformed into z-
scores. Mean and standard deviations (SDs) for each test were 
calculated from the scores of 500 age-gender-matched subjects 
from the same ADRC data set who had neither dementia nor 
amnestic mild cognitive impairment nor non-amnestic mild 
cognitive impairment according to consensus at the consensus 
conference. There were no significant differences between AD 
patients and controls regarding age, gender, duration of educa-
tion, ethnicity, and frequency of silent or symptomatic infarcts. 
Mean z-scores for each cognitive domain were calculated. 
Some individual test scores were missing; however, the domain 
measure was calculated when at least half of the individual 
scores were available.
Statistical analyses
We compared the demographic features of AD patients accord-
ing to the presence of symptomatic cerebral infarcts using a 
non-parametric test for continuous variables and chi-square 
test for categorical variables. We evaluated the influence of 
symptomatic infarcts on the scores of the each cognitive do-
main measures using linear regression. The first linear regres-
sion analyses included symptomatic infarcts as an independent 
variable and cognitive domain measures as dependent vari-
ables. These were adjusted for age, sex, education, and ethnici-
ty. After initial analysis, additional covariates were added to the 
model. We adjusted for diabetes mellitus, hypertension, heart 
disease, and the clinical dementia rating. In further regression 
analyses, we additionally adjusted for silent infarct, multiplicity 
of radiological infarcts, and location of radiological infarcts.
Ethics statement
This study was approved by the institutional review board of the 
New York State Psychiatric Institute (Protocol #5467R). All sub-
jects gave informed consent for participation in this study. This 
study followed Good Clinical Practice, consistent with the In-
ternational Conference on Harmonization (ICH) ethical princi-
ples for medical research involving human subjects, and with 
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RESULTS
Sample characteristics
By NINCDS-ADRDA criteria, there were 522 probable AD pa-
tients and 479 possible AD patients. Most of the latter were des-
ignated as possible due to the presence of concomitant vascu-
lar or psychiatric dysfunction. Severity of dementia, classified 
by Clinical Dementia Rating (CDR) scale, was CDR 1 in 726 pa-
tients (72.5%), CDR 2 in 206 patients (20.6%), and CDR 3 in 69 
patients (6.9%). A total of 503 infarcts were detected in the fol-
lowing locations: frontal 34; temporal 14; parietal 28; occipital 
17; thalamus 51; basal ganglia 106; white matter 161; brainstem 
27; cerebellum 32, and unclassified 33. Among 308 patients 
with radiological infarcts, 188 patients had a single lesion and 
the remaining 120 patients had multiple lesions. Neuroimag-
ing, included MRI was performed in 59.9% of patients and CT 
alone in 40.1% of patients. The time between brain imaging and 
neuropsychological evaluation was somewhat greater for CT 
(9.9 ± 18.9 months) compared to MRI (7.2 ± 13.7 months, P = 
0.01).
  AD patients with symptomatic infarcts were older than those 
without (P = 0.03). Comparisons of other characteristics were 
not different between groups including imaging modality us-
age and duration between neuropsychological evaluation and 
neuroimaging (Table 1). 
Influence of symptomatic infarcts on cognitive 
performance in AD
AD patients with a symptomatic infarct had poorer scores for 
executive function, irrespective of adjustment for age, gender, 
education, and ethnicity. This significance was persistent after 
four additional adjustments with vascular risk factors (hyper-
tension, diabetes, and heart diseases) and CDR, silent infarct, 
multiple infarct, and frontal infarcts (Table 2). AD patients with 
a symptomatic infarct also had poorer scores in language and 
visuospatial performance after adjustment for age, gender, edu-
cation, ethnicity, and multiple infarcts, but not in the other 
analyses.
  Silent infarcts, multiple infarcts, and frontal infarcts had no 
discernible influence on any cognitive performance. Other lo-
cations of infarcts could not be added to the model due to inad-
equate of model fitness (variance inflation > 10). 
  When the analysis was limited to 962 patients by excluding 
those who had history of stroke without radiological infarcts, AD 
patients with a symptomatic infarct still had poorer scores for 
executive function in all models. When the analysis included 
only the 553 patients who had undergone MRI within one year 
of testing, AD patients with symptomatic infarcts still had poor-
er scores for executive function (β, -0.15; 95% CI: -0.60 to -0.09; 
P = 0.01). Only 4 patients had symptomatic infarcts among the 
522 patents with probable AD and the influence of symptomat-
ic infarcts disappeared in the separated analysis in probable AD 
patients.
DISCUSSION
Consistent with results from other studies of non-demented el-
derly (4-6, 18), symptomatic infarcts in patients with AD like-
wise had an additional unfavorable influence on cognition, 
Table 1. Alzheimer’s disease patients with silent or symptomatic infarcts
Parameters
Silent infarcts  
(n = 933)
Symptomatic  
infarcts (n = 68)
P value
Age, yr, mean (SD)   75.3 (9.5) 78.2 (7.4) 0.03
Education, yr, mean (SD)    11.1 (5.0) 10.0 (5.4) 0.11
Gender, males (%)   305 (32.7) 30 (44.1) 0.05
Ethnicity
   White or Others (%)
   African American (%) 
   Hispanic (%)
 
58.1
14.5
27.4
 
51.6
  9.4
39.1
0.10
CDR
   CDR 1 (%)
   CDR 2 (%)
   CDR 3 (%)
 
73.3
19.8
  6.9
 
61.8
30.9
  7.4
0.08
Hypertension (%) 48.2 59.4 0.08
Diabetes mellitus (%) 15.0 23.0 0.10
Heart disease (%) 10.2 14.1 0.30
Brain MRI (%) 59.5 69.1 0.12
CDR, clinical dementia rating.
Table 2. Linear regression models of symptomatic infarcts examining different cognition profiles 
Risk factors
β/standard error (upper line) and P value (lower line) of cognition profiles
Memory Executive function Language Visuospatial Abstract reasoning
Model 1 (adjusted for age, gender, education  
   and ethnicity) 
-0.11/0.09
0.22
-0.27/0.09
0.004
-0.37/0.19
0.05
-0.29/0.15
0.06
-0.02/0.15
0.91
Model 1 plus vascular risk factors* and CDR -0.09/0.09
0.31
-0.27/0.10
0.005
-0.32/0.20
0.11
-0.29/0.16
0.07
0.01/0.16
0.79
Model 1 plus silent infarcts -0.07/0.09
0.46
-0.26/0.10
0.008
-0.31/0.20
0.13
-0.29/0.16
0.08
0.07/0.16
0.66
Model 1 plus multiple infarct (≥ 2 infarcts) -0.11/0.09
0.24
-0.25/0.10
0.01
-0.043/0.21
0.04
-0.36/0.17
0.03
0.04/0.17
0.83
Model 1 plus frontal infarcts  -0.14/0.10
0.10
-0.31/0.10
0.003
-0.38/0.21
0.07
-0.29/0.17
0.09
-0.03/0.17
0.86
*Hypertension, diabetes mellitus, and heart diseases. CDR, clinical dementia rating.Cho S-J, et al.  •  Influence of Symptomatic Cerebral Infarcts on Cognition in Alzheimer’s Disease
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even after considering the severity of AD. This result is consis-
tent with described cognitive changes after symptomatic stroke 
in AD (19, 20). A decline in executive performance was noted 
regardless of the multiplicity or location of infarcts, within the 
limits of this study. Executive dysfunction may be related to in-
jury to the frontal-subcortical network, or possibly related to 
other infarct locations (21). 
  We did not find a detrimental effect of silent radiological in-
farcts in AD patients, unlike some studies of non-demented el-
derly or patients with mild AD (4, 10). Usually, silent infarcts 
have a smaller volume and are located in non-eloquent areas 
compared to symptomatic infarcts; therefore, it is difficult to 
detect minimal changes resulting from minor infarcts, especial-
ly in severe or neocortical stage AD. 
  The strengths of our study included a large multiethnic refer-
ral population, separate consideration of symptomatic infarcts 
and silent infarcts, examination of several cognitive domains, 
and adjustment for multiple covariates. There are also a num-
ber of limitations to this study. First, we were unable to examine 
the various factors that may have influenced the associations 
identified, such as the timing of symptomatic infarcts, subtypes 
of stroke, the presence of white matter hyperintensities (22). 
Second, numbers of patients with severe dementia are small 
compared to those with mild to moderate dementia. Also, there 
are many fewer patients with symptomatic cerebral infarcts, 
than with silent infarcts, althouth this reflects actual prevalenc-
es (11). Third, we do not have validation of diagnosis of AD with 
autopsy findings, so there is a possibility of misdiagnosis of vas-
cular dementia as AD. However, AD patients with symptomatic 
infarcts apt to be classified into possible AD regardless of bur-
den of AD pathology. Therefore, it might be impossible to study 
the influence of symptomatic infarct after excluding possible 
AD patients. Finally, the analysis here involves data accumulat-
ed over a 16 yr (1991-2005), with accompanying difference in 
imaging modalities and varying time intervals between neuro-
imaging study and the neuropsychological evaluation. Addi-
tionally, executive function was not evaluated by the other tests 
for frontal-executive function (23). 
  Despite these potential limitations, our results support the 
hypothesis that symptomatic cerebral infarcts in the AD popu-
lation may provide an additive “non-memory” factor contribut-
ing to dementia and the influence of cerebral infarcts is neither 
general nor diffuse, and the presence of clinical history may 
have a more important influence on executive performance in 
AD.  
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